Health
The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Read Full Article at www.npr.org
Original story published by www.npr.org. Peanutlife curates and shares uplifting news to brighten your day.
